BB BIOTECH NAM. SF 0,20/ CH0038389992 /
20.12.2024 19:18:30 | Изменение +0.3000 | Объем сделки | Бид20:08:02 | Предложение19:18:30 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
37.8000EUR | +0.80% | 6,416 Оборот: 238,870.1500 |
-Величина цены спроса: - | -Величина цены предложения: - | 2.11 млрдEUR | - | - |
GlobeNewswire
28.03
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire
17.06.2021
Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
GlobeNewswire
16.12.2019
Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire
19.10.2018
Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire
02.01.2018
Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire
19.10.2017
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire
02.12.2016
Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire
29.07.2016
Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire
15.07.2016
BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire
14.07.2016
BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница